because apo-e serves as a recognition determinant for the receptor-mediated clearance of lipoproteins , the decreased synthesis of apo-e after lps treatment may in part explain the hyperlipoproteinemia associated with endotoxins in vivo .
C0003595
apo-e
C0020476
hyperlipoproteinemia